Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SOXL vs GSK✓SelectedUSD · GSKSOXL vs GSK performance historyLatest closeAs of-31.83%11/20
Stock and ETF performance explorer

SOXL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+828.3%
GSK return
+97.4%
Excess return
+730.9%
Maximum drawdown
-90.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-31.8%-0.1%-31.7%-31.7%
7D-47.1%-5.3%-41.7%-44.6%
30D-70.1%-3.7%-66.4%-69.5%
3M-74.7%-7.3%-67.5%-73.9%
6M-82.2%-4.2%-77.9%-83.1%
YTD-26.5%+0.9%-27.3%-35.7%
1Y+0.3%+7.3%-7.0%-17.7%
3Y+30.0%+52.7%-22.8%-38.3%
5Y-53.6%+40.1%-93.7%-77.0%
All+828.3%+97.4%+730.9%+281.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling